Soc. Generale Knock-Out MRK/ DE000CL9FJ52 /
5/31/2024 9:43:23 PM | Chg.+0.180 | Bid9:51:32 PM | Ask9:51:32 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
9.450EUR | +1.94% | 9.460 Bid Size: 3,000 |
9.530 Ask Size: 3,000 |
MERCK KGAA O.N. | 71.7424 - | 12/31/2078 | Call |
GlobeNewswire
2:38 AM
Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pe...
GlobeNewswire
5/29
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire
5/7
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
5/6
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
3/4
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
12/21/2023
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
12/14/2023
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
10/17/2023
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA